Centre nods for new AIIMS in Tamil Nadu and Telangana


The Central Government has given its nod to set up two new All India Institutes of Medical Sciences (AIIMS) — one each in Tamil Nadu and Telangana.

The two new institutes will be set up under the Pradhan Mantri Swasthya Suraksha Yojana (PMSSY). One of the institutes would come up at Madurai district of Tamil Nadu at a cost of Rs 1,264 crore, while in Telangana, the premier healthcare institute will be set up at Bibinagar at a cost of Rs 1,028 crore.

Setting up of new AIIMS would not only transform health education and training but also address the shortfall of health care professionals in the region,” and official statement said.

According the statement, with 100 UG (MBBS) seats and 60 BSc (Nursing) seats, each new AIIMS will have 15-20 super specialty departments and also a hospital of 750 beds. As per data of current functional AIIMS, it is expected that each new AIIMS would cater to around 1,500 outdoor patients per day.

The proposed institution with 750 bed hospitals will include emergency/trauma beds, AYUSH beds, private beds and ICU specialty and super specialty beds. In addition, the institutions will also have a medical college, AYUSH block, auditorium, night shelter, guest house, hostels and residential facilities.

Construction of new AIIMS is fully funded by the Central Government. The recurring cost on these institutions shall be met through grant-in-aid to them from plan budget head of PMSSY of Ministry of Health.

The new AIIMS are scheduled to be functional within 45 months. The duration comprises a pre-construction phase of 10 months, construction phase of 32 months and stabilisation/commissioning phase of 3 months.

"Exciting news! Elets Education is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!
Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.